Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment and Treatment of Negative Symptoms in Schizophrenia—A Regional Perspective
István Bitter, Pavel Mohr, Natalia Raspopova, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 20

Showing 20 citing articles:

Is it more effective for anhedonia and avolition? A systematic review and meta‐analysis of non‐invasive brain stimulation interventions for negative symptoms in schizophrenia
Yuying Chen, Zhuofeng Li, Chao Yan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 6
A comparative view of human and mouse telencephalon inhibitory neuron development
Changuk Chung, Joseph G. Gleeson, Joseph G. Gleeson
Development (2025) Vol. 152, Iss. 1
Closed Access
Intermittent theta burst stimulation for negative symptoms in schizophrenia patients with mild cognitive impairment: a randomized controlled trail
Jing Li, Xian Mo, Dan Jiang, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping
Armida Mucci, Stefan Leucht, Giulia Maria Giordano, et al.
Brain Sciences (2025) Vol. 15, Iss. 1, pp. 83-83
Open Access
Short-chain fatty acids in patients with schizophrenia and ultra-high risk population
Huiqing Peng, Lijun Ouyang, David Li, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 16
Cognition in Patients with Schizophrenia: Interplay between Working Memory, Disorganized Symptoms, Dissociation, and the Onset and Duration of Psychosis, as Well as Resistance to Treatment
Georgi Panov, Silvana Dyulgerova, Presyana Panova
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3114-3114
Open Access | Times Cited: 9
A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia
Panneer Selvan, Prashant Devkare, Arthik Shetty, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3
The management of patients with predominant negative symptoms in Slovakia: A 1-year longitudinal, prospective & multicentric cohort study
Jozef Dragašek, Z.B. Dombi, K. Acsai, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 2
Crocus sativus (saffron) adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled trial
Siamand Mazhar, Ahmad Shamabadi, Kimia Kazemzadeh, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 2
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study
Giulia Maria Giordano, Pasquale Pezzella, Luigi Giuliani, et al.
Brain Sciences (2023) Vol. 13, Iss. 1, pp. 83-83
Open Access | Times Cited: 6
RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
Clàudia Aymerich, Ana Catalán, Gonzalo Salazar de Pablo
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 336-336
Open Access | Times Cited: 1
Prodromal period of psychosis: diagnostic criteria
Олена Венгер, Volodymyr Bilous, Olena Striepetova, et al.
Wiadomości Lekarskie (2024) Vol. 77, Iss. 1, pp. 47-54
Open Access
Dynamics of apatho-abolic manifestations in patients with negative symptoms in schizophrenia
N. Maruta, Yu. A. Kushnir
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 2, pp. 270-274
Open Access
Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study
Noham Wolpe, Shanquan Chen, Brian Kirkpatrick, et al.
The British Journal of Psychiatry (2023) Vol. 223, Iss. 1, pp. 336-337
Open Access
Editorial: Clinical guidelines in schizophrenia: applications and evaluation
Shinsuke Hidese, Signe Wegmann Düring, Rafael Penadés
Frontiers in Psychiatry (2023) Vol. 14
Open Access
ДИНАМІЧНА ХАРАКТЕРИСТИКА СОЦІАЛЬНОЇ ВЗАЄМОДІЇ ТА ОСОБЛИВОСТЕЙ ПСИХОСОЦІАЛЬНОЇ АДАПТАЦІЇ СЕРЕД ПАЦІЄНТІВ З НЕГАТИВНИМИ СИМПТОМАМИ ПРИ ШИЗОФРЕНІЇ
Юрій Кушнір
Перспективи та інновації науки (2023), Iss. 16(34)
Open Access
POSSIBILITIES OF USING THE SANS METHOD FOR ASSESSING THE DYNAMICS OF ANHEDONIA AND ASOCIALITY IN PATIENTS WITH NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
Y. Kushnir
Ukrains kyi Visnyk Psykhonevrolohii (2023), Iss. Volume 31, issue 4 (117), 2023, pp. 89-93
Closed Access
Recovering quality of life in outpatients with psychosis spectrum disorders and its association with the symptom domains
Nadja Marić, Ivan Ristić, Stefan Jerotić, et al.
Medicinska istrazivanja (2022) Vol. 55, Iss. 1, pp. 43-49
Open Access
Motivation Disorders in Patients with Schizophrenia
M. V. Kuzminova, Т. А. Солохина, A. I. Nochevkina
Psikhiatriya (2022) Vol. 20, Iss. 3, pp. 65-73
Open Access
Zavod za kliničku psihijatriju: jučer, danas i sutra
Marina Šagud, Alma Mihaljević-Peleš, Bjanka Vuksan Ćusa, et al.
Socijalna psihijatrija (2022) Vol. 50, Iss. 2, pp. 110-126
Open Access
Zavod za kliničku psihijatriju: jučer, danas i sutra
Marina Šagud, Alma Mihaljević-Peleš, Bjanka Vuksan Ćusa, et al.
Socijalna psihijatrija (2022) Vol. 50, Iss. 2, pp. 110-126
Open Access
Page 1

Scroll to top